We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORA:EURONEXT PARISOrange SA Analysis

Data as of 2026-08-28 - not real-time

$102.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ormat Technologies, Inc. is priced at $102.60 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 2.0% over the past 30 days. RSI sits at 40.7, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $95.08 and resistance around $117.01.
The shares look fair, trading on 50.3 times earnings above a sector average of 19.4. Analyst price targets sit 29.5% above the current price. Revenue is growing at 10.6% on a 10.7% profit margin. The 0.46% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 44.0%, a beta of 0.89 and a maximum drawdown of 35.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top Market Events

In early August 2026, Ormat Technologies, Inc.Ormat Technologies ORA possesses the right combination of the two key ingredients for a likely earnings beat in its...Ormat Technologies, Inc. NYSE:ORA is one of the 15 Best Power Generation Stocks To Buy For Data Center Demand. On May...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 115.62
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 50.3 versus sector average of 19.4
  • Trading below the 200-day average of 115.62

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 50.3 versus sector average of 19.4
  • Analyst targets imply +29.5% versus the current price
  • Revenue growth of +10.6%

Key Metrics & Analysis

Financial Health

Revenue Growth10.60%
Profit Margin10.66%
P/E Ratio50.3
ROE4.78%
ROA2.04%
Debt/Equity124.34
P/B Ratio2.4
Op. Cash Flow$279.4M
Free Cash Flow$-318099008
Industry P/E19.4

Technical Analysis

TrendBearish
RSI40.7
Support$95.08
Resistance$117.01
MA 20$107.63
MA 50$108.58
MA 200$115.62
MACDBearish
VolumeDecreasing
Fear & Greed Index95.25

Valuation

Fair Value$16.70
Target Price$132.83
Upside/Downside29.47%
GradeFair
TypeGrowth
Dividend Yield0.46%

Risk Assessment

Beta0.89
Volatility43.96%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.